This extends prior smaller studies where PCSK9 has been positively associated with obesity cross-sectionally27,28, and is particularly notable in light of the known role of PCSK9 levels in LDL cholesterol metabolism and atherosclerosis development29–31. Here, PCSK9 is linked to obesity due to melanocortin 4 receptor deficiency.